Skip to content
Open access

Inflammasome activation promotes the progression of myelodysplastic syndrome.

Oct 2026 · Experimental Hematology · pp. 105960 · 0 citations · 40 references
Medicine

TL;DR

It is suggested that targeting inflammasome signaling may represent a potential therapeutic approach for MDS through deleting Asc, an adaptor protein that links inflammasome sensor proteins to caspase-1.

Abstract

Inflammasomes are multiprotein complexes that sense pathogen- and damage-associated molecular patterns and induce inflammatory responses and have been implicated in the pathogenesis of myelodysplastic syndrome (MDS). However, their functional contribution to MDS progression in vivo have not yet been elucidated. Here, we investigated the effects of inflammasome inhibition in mouse models of MDS by deleting Asc, an adaptor protein that links inflammasome sensor proteins to caspase-1. Asc-deficient mice showed no significant hematopoietic defects under steady-state conditions or in competitive bone marrow reconstitution assays. In an MDS mouse model co-expressing CBLΔE8/9 and RUNX1S291fs, mice developed MDS and eventually progressed to acute myeloid leukemia regardless of Asc status. However, compared with wild-type MDS mice, which progressed to lethal MDS, Asc-deficient MDS mice exhibited attenuated caspase-1 activation, delayed MDS progression, and significantly prolonged survival. Asc deficiency also substantially attenuated the MDS phenotypes induced by Tet2 deficiency. Levels of IL-1β and/or IL-18, key inflammatory cytokines produced downstream of inflammasome activation, were elevated in the bone marrow fluid of these MDS models and reduced by Asc deficiency. These findings demonstrate that ASC-dependent inflammasome signaling contributes to MDS progression in vivo and suggest that targeting inflammasome signaling may represent a potential therapeutic approach for MDS. Teaser Abstract We investigated the effects of inflammasome inhibition in mouse models of MDS by deleting Asc, an adaptor protein that links inflammasome sensor proteins to caspase-1. In an MDS mouse model, mice developed MDS and eventually progressed to acute myeloid leukemia regardless of Asc status. However, compared with wild-type MDS mice, which progressed to lethal MDS, Asc-deficient MDS mice exhibited attenuated caspase-1 activation, delayed MDS progression, and significantly prolonged survival. Asc deficiency also substantially attenuated the MDS phenotypes induced by Tet2 deficiency. These findings demonstrate that ASC-dependent inflammasome signaling contributes to MDS progression in vivo.

Read PDF

Similar papers

Open access Sep 2026

Myeloid STING-ZBP1 Axis Drives Atherosclerosis by Inducing Macrophage PANoptosis

The STING-ZBP1 signaling cascade is established as a central regulator of macrophage PANoptosis during atherogenesis and a previously unrecognized mechanism linking innate immune signaling to inflammatory cell death in atherosclerosis is uncovered, highlighting this pathway as a promising therapeutic target for atheros...

Hong Zhou, Yue-Qing Han, Danmei Liu et al. · 0 citations
Nov 2026

MicroRNA dysregulation in mesenchymal stromal cells in myelodysplastic syndromes and its modulation by azacitidine and bortezomib.

Myelodysplastic syndromes (MDS) are clonal disorders of hematopoietic stem and progenitor cells characterized by ineffective hematopoiesis, bone marrow dysplasia and variable progression to acute myeloid leukemia. Mesenchymal stromal cells (MSCs) contribute to MDS pathogenesis through mechanisms partly mediated by micr...

Maria Carolina Ottati, M. Boada, L. Spangenberg et al. · 0 citations
Review Open access Sep 2026

PIM1 in myeloproliferative neoplasms: potential pathogenic and therapeutic implications

Myeloproliferative neoplasms (MPNs) are clonal hematologic malignancies characterized by the overproduction of mature myeloid lineage cells. Although JAK2 inhibitors, such as ruxolitinib, can alleviate constitutional symptoms, they typically fail to eradicate malignant clones or reverse bone marrow fibrosis. Moreover,...

Avik Dutta, L. Varricchio, Ronald Hoffman et al. · 0 citations
Review Open access Oct 2026

Genetic and Immunologic Interactions Driving STAT3 Signaling and Macrophage Polarization in Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is an increasingly recognized malignancy sustained by a dysregulated inflammatory niche, in which genetic alterations and microenvironmental signaling converge to drive pathogenesis. This review synthesizes emerging evidence linking genetic mutations and immune dysregulation in AML, proposi...

K. O. Ahmed, M. A. Ahmed, G. Othman et al. · 0 citations
Open access Nov 2026

NUDT21 knockdown modulates alternative polyadenylation and promotes leukemic transformation in myelodysplastic syndromes.

Progression of myelodysplastic neoplasms (MDS) to secondary acute myeloid leukemia (sAML) involves complex clonal evolution; however, the role of alternative polyadenylation (APA) regulators such as NUDT21 remains unclear. This study aimed to investigate the effects of NUDT21 knockdown on gene expression profiles in MD...

Shuo Li, Jia-Kai Bian, Pei-Chun Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.